Cibus, Inc. (NasdaqCM: CBUS)
Health Care · Biotechnology · US
$1.48
-4.52% today · +5.4% 1Y
Cibus, Inc. (NasdaqCM: CBUS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $118.46M and employs 118 people.
Over the last twelve months the share price has gained 5.4%, trading between 1.09 and 4.19.
Tweenvest scores Cibus, Inc. across four factors: quality 33/100, value 58/100, growth 63/100. Its strongest factor is growth.
CBUS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $118.46M
- Revenue (TTM)
- $4.35M
- P/E
- —
- EPS
- -1.58
- Dividend yield
- —
- Beta (5Y)
- 1.57
- 52-week high
- $4.19
- 52-week low
- $1.09
- Avg volume (3M)
- —
- Shares outstanding
- 76.43M
- Employees
- 118
- Next earnings
- —
About Cibus, Inc.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
- ISIN
- US17166A1016
- Founded
- 2010
- Listed since
- Jul 20, 2017
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Kazia Therapeutics LimitedNasdaqCM: KZIA | $122.37M | $8.81 | -1.34% |
| ISU Abxis Co., Ltd.KOSDAQ: A086890 | $120.71M | ₩3,980.00 | +3.51% |
| Anterogen.Co.,Ltd.KOSDAQ: A065660 | $120.50M | ₩16,190.00 | +7.65% |
| Foghorn Therapeutics Inc.NasdaqGM: FHTX | $118.77M | $1.95 | -2.50% |
| Nykode Therapeutics ASOB: NYKD | $117.42M | Nkr3.41 | -0.87% |
| Oncopeptides AB (publ)OM: ONCO | $117.17M | Skr2.96 | +40.74% |
| Heidelberg Pharma AGXTRA: HPHA | $116.82M | €2.23 | -5.11% |
| Coya Therapeutics, Inc.NasdaqCM: COYA | $116.12M | $4.81 | -2.83% |
Figures last refreshed Oct 11, 2026.